Straumann Holding AGXSWX:STMN +1.81%99 FCF Margin % is 13.84% as of Dec. 2025, which is 3% above its 10-year median of 13.43. GuruFocus rates XSWX:STMN with a GF Score™ of 99/100 and a GF Value™ of CHF136.92 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Straumann Holding AG ranks better than 75.09% on this metric.
The historical rank and industry rank for Straumann Holding AG's FCF Margin % or its related term are showing as below:
XSWX:STMN'
s FCF Margin % Range Over the Past 10 Years
Min: 9.47 Med: 13.43 Max: 21.73
Current: 10.77
During the past 13 years, the highest FCF Margin % of Straumann Holding AG was 21.73%. The lowest was 9.47%. And the median was 13.43%.
XSWX:STMN's FCF Margin % is ranked better than 75.09% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.1
vs XSWX:STMN: 10.77
Straumann Holding AG FCF Margin % Related Terms
Straumann Holding AG FCF Margin % Historical Data
* Premium members only.
The historical data trend for Straumann Holding AG's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:STMN vs ISRG, BDX, MDLN: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Straumann Holding AG's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Straumann Holding AG FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Straumann Holding AG's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Straumann Holding AG's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Straumann Holding AG (XSWX:STMN) has a FCF Margin % of 13.84% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Straumann Holding AG and its competitors. This is near median its historical median of 13.43. Over the past decade, Straumann Holding AG's FCF Margin % has ranged from 9.47 to 21.73. According to the industry distribution chart, Straumann Holding AG ranks #203 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 24.9%.
Is Straumann Holding AG's FCF Margin % too high?
Straumann Holding AG's current FCF Margin % of 13.84% is near median its 10-year median of 13.43. Over the past 10 years, this metric has ranged from a low of 9.47 to a high of 21.73. Based on the distribution chart, Straumann Holding AG ranks #203 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Straumann Holding AG has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Straumann Holding AG's FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Straumann Holding AG ranks #203 out of 815 companies for FCF Margin %. This places Straumann Holding AG in the top 25% of its industry — outperforming the majority of peers. Historically, Straumann Holding AG's own FCF Margin % has ranged from 9.47 to 21.73 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Straumann Holding AG and its competitors. Straumann Holding AG's current FCF Margin % is 13.84%, which is near median its own 10-year median of 13.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Straumann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Straumann Holding AG (XSWX:STMN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF136.92, compared to a current price of CHF106.80 — trading 22% below its estimated fair value. The current FCF Margin % is 13.84%, which is near median its 10-year median of 13.43. Straumann Holding AG's overall GF Score™ is 99/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Straumann Holding AG (XSWX:STMN), the current FCF Margin % is 13.84% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Straumann Holding AG (XSWX:STMN) Overvalued in 2026?
Based on GuruFocus' analysis, Straumann Holding AG stock appears to be undervalued.
The current stock price of CHF106.80 is trading 22% below its estimated GF Value™ of CHF136.92.
GuruFocus considers Straumann Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:STMN:
FCF Margin %: 13.84% (near median its 10-year median of 13.43)
GF Value™: CHF136.92 vs. price of CHF106.80 (22% below fair value)
No single metric tells the full story. See the XSWX:STMN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it holds over one third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.
99GF Score
Get the complete analysis for XSWX:STMN
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:STMN has been successfully added to your 
